Zhaoke Ophthalmology’s Biologics License Application for TAB014 for wAMD Accepted for Review by the NMPA

Zhaoke Ophthalmology Obtains FDA Clearance for CsA Ophthalmic Gel’s IND Application in the U.S.

Zhaoke Ophthalmology’s New Drug Application for Self-Developed CsA Ophthalmic Gel is Accepted for Review by the NMPA

Zhaoke Ophthalmology Enrols the First Patient for the Additional Phase III Clinical Trial of the Self-Developed Innovative Drug CsA Ophthalmic Gel

Zhaoke Ophthalmology Recruits First Patient for Innovative Presbyopia Drug BRIMOCHOLTM PF’s Phase II Trial and Expands Presence in the Middle East